Opinion statement
Microcystic adnexal carcinoma (MAC) is a rare, slow-growing, infiltrative malignant tumour most commonly found on the head and neck. It often presents as a solitary skin-coloured or yellow papule, plaque or nodule. Ultraviolet radiation, immunosuppression and ionising radiation are possible risk factors. Clinical and histological differential diagnoses include morpheaform basal cell carcinoma and desmoplastic trichoepithelioma. The diagnosis is usually made by skin biopsy, and the characteristic features are small keratin-filled cysts with nests and cords which resemble ductal structures. Immunohistochemistry can assist in differentiating MAC from other tumours. The local aggressive nature of the tumour and its potential to infiltrate beyond the assessed clinical margins warrant complete excision with margin control, and we recommend Mohs micrographic surgery. Wide local excision is widely performed but is associated with recurrence given its infiltrative nature and extensive subclinical extension. The role of radiotherapy in the management of MAC is unclear.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma: a distinct clinicopathologic entity. Cancer. 1982;50:566.
Lipper S, Peiper SC. Sweat gland carcinoma with syringomatous features: a light microscopic and ultrastructural study. Cancer. 1979;44:157–63.
Cooper PH, Mills SE. Microcystic adnexal carcinoma. J Am Acad Dermatol. 1984;10:908–14.
Cooper PH, Mills SE, Leonard DD, Santa Cruz DJ, Headington JT, Barr RJ, et al. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol. 1985;9:422–33.
Cooper PH. Sclerosing carcinomas of sweat ducts (microcystic adnexal carcinoma). Arch Dermatol. 1986;122:261–4.
Santa Cruz DJ. Sweat gland carcinomas: a comprehensive review. Semin Diagn Pathol. 1987;4:38–74.
Requena L, Marquina A, Alegre V, Aliaga A, Sanchez Yus E. Sclerosing (microcystic adnexal) carcinoma: a tumour from a single eccrine origin. Clin Exp Dermatol. 1990;15:222–4.
Sebastien TS, Nelson BR, Lowe L, Baker S, Johnson TM. Microcystic adnexal carcinoma. J Am Acad Dermatol. 1993;29:840–5.
Yu JB, Blitzbau RC, Patel SC, et al. Surveillance, Epidemiology and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol. 2010;33:125.
Caroll P, Goldstein GD, Brown CW Jr. Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol Surg. 2000;26:531.
Snow S, Madjar DD, Hardy S, et al. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg. 2001;27:401.
Schwarze HP, Loche F, Lamant L, et al. Microcystic adnexal carcinoma induced by multiple radiation therapy. Int J Dermatol. 2000;39:369.
McAlvany JP, Stonecipher MR, Leshin B, et al. Sclerosing sweat duct carcinoma in an 11-year-old boy. J Dermatol Surg Oncol. 1994;20:767.
Ps N, Bourgeois KM, Nicotri T Jr, et al. Sclerosing sweat duct carcinoma in a 6-year-old African American child. Paediatr Dermatol. 2008;25:38.
Smart DR, Taintor AR, Kelly ME, et al. Microcystic adnexal carcinoma: the first reported congenital case. Paeditr Dermatol. 2011;28:35.
Fu T, Clark FL, Lorenz HP, Bruckner AL. Congenital microcystic adnexal carcinoma. Arch Dermatol. 2011;28:35.
Hamed NS, Khachemoune A. Microcystic adnexal carcinoma: a focused review and updates. J Dermatol Dermatologic Surg. 2015;19:20–5.
• Chaudhari BA, Blanchard L, Chaudhari PJ, Lythgoe T. The first reported case of metastatic microcystic adnexal carcinoma in an adolescent. Dermatol Surg. 2015;41:286–8. This is the first ever case report in the literature of metastatic microcystic adnexal carcinoma in an adolescent
Leibovitch I, Huilgol SC, Selva D, et al. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52:295.
Sellheyer K, Nelson P, Kutzner H, Patel RM. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers. J Cutan Pathol. 2013;40:363–70.
Krahl D, Sellheyer K. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma. J Cutan Pathol. 2007;34:782–7.
Sellheyer K, Krahl D. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoiec basal cell carcinoma and desmoplastic trichoepithelioma. Br J Dermatol. 2011;164:141–7.
• Giambrone D, Salvaggio C, Victor FC, Rao BK. Microcystic adnexal carcinoma detected by reflectance confocal microscopy. Dermatol Surg. 2016;42:126–7. This letter of correspondence is the first case in which reflectance confocal microscopy has been used to detect microcystic adnexal carcinoma
• Alawi SA, Batz S, Rowert-Huber J, Fluhr JW, et al. Correlation of optical coherence tomography and histology in microcystic adnexal carcinoma: a case report. Skin Res Technol. 2015;21:15–7. This is the first case report of optical coherence tomography criteria for microcystic adnexal carcinoma correlated with conventional histopathology
Salerno S, Terrill P. Will MAC be back? ANJ J Surg. 2003;73:830–2.
Leboit PE, Sexton M. Microcystic adnexal carcinoma of the skin. J Am Acad Dermatol. 1993;29:609–18.
Burns MK, Chen SP, Goldberg LH. Microcystic adnexal carcinoma. Ten cases treated by Mohs micrographic surgery. J Dermatol Surg Oncol. 1994;20:429–34.
Friedman PM, Friedman RH, Jiang B, Nouri K, Amonette R, Robins P. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol. 1999;41:225–31.
Abbate M, Zeitouni N, Seyler M, Hicks W, Loree T, Cheney RT. Clinical course, risk factors and treatment of microcystic adnexal carcinoma: a short series report. Dermatol Surg. 2003;29:1035–8.
Leibovitch I, Huilgol SC, Richards S, Paver R, Selva D. Periocular microcystic adnexal carcinoma: management and outcome with Mohs micrographic surgery. Opthalmologica. 2006;220:109–13.
Wetter R, Goldstein GD. Microcystic adnexal carcinoma: a diagnostic and therapeutic challenge. Dermatol Ther. 2008;21:452.
Baxi S, Deb S, Weedon D, Baumann K, Poulsen M. Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy. J Med Imag and Rad Oncol. 2010;54:477–82.
•• Mestre T, Oliphant T, Lawrence CM, Barnes E, Clarke L, Dickinson J, et al. Mohs micrographic surgery is the required treatment for periocular microcystic adnexal carcinoma to maximise the possibility of tumour clearance. Br J Dermatol. 2016;175(S1):119. This 10-year case series review demonstrates the high incidence of perineural invasion in periocular microcystic adnexal carcinoma and advocates the use of Mohs micrographic surgery at this high-risk site
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Skin Cancer
Rights and permissions
About this article
Cite this article
Aslam, A. Microcystic Adnexal Carcinoma and a Summary of Other Rare Malignant Adnexal Tumours. Curr. Treat. Options in Oncol. 18, 49 (2017). https://doi.org/10.1007/s11864-017-0491-z
Published:
DOI: https://doi.org/10.1007/s11864-017-0491-z